RecruitingNCT04699305
Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers
Sponsor
RedDress Ltd.
Enrollment
500 participants
Start Date
Feb 14, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Subject is ≥18 years of age
- Subject has an exuding cutaneous wound
- Subject agrees to the use of his health data, including photos of his wound in analysis and publications
- Subject/LAR must be able to read and understand English and/or Spanish
Exclusion Criteria1
- Subject/LAR is unable to read and understand English or Spanish.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEActiGraft
Whole blood clot (WBC) gel
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04699305